Atlas Trials

Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia

Clinical trial NCT04546607 · COMPLETED

Trial details

NCT number
NCT04546607
Sponsor
Natureceuticals Sdn Bhd
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
AstheniaCancer
Start date
2017-09-02
Primary completion
2019-10-28
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.